Hepatocellular carcinoma (HCC):: Can it still be considered a controversial indication for liver transplantation (LT)?

被引：0
|
作者：
Nicolás, D
Berenguer, M
Pastor, M
Aguilera, V
Ortiz, V
Moya, A
Prieto, M
San Juan, F
Carrasco, D
Mir, J
Berenguer, J
机构：
[1] Hosp Univ La Fe, Serv Med Digest, Valencia, Spain
[2] Hosp Univ La Fe, Unidad Cirugia & Trasplante Hepat, Valencia, Spain
来源：
JOURNAL OF HEPATOLOGY | 2000年 / 32卷
关键词：
D O I：
10.1016/S0168-8278(00)80536-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Hepatocellular carcinoma:: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya, A
    Berenguer, M
    Aguilera, V
    San Juan, F
    Nicolás, D
    Pastor, M
    López-Andujar, R
    Rayón, M
    Orbis, F
    Mora, J
    de Juan, M
    Carrasco, D
    Vila, JJ
    Prieto, M
    Berenguer, J
    Mir, J
    LIVER TRANSPLANTATION, 2002, 8 (11) : 1020 - 1027
  • [2] Prognostic factors associated with liver transplantation (LT) for hepatocellular carcinoma (HCC)
    Duvoux, C
    Traissac, L
    Roudot-Thoraval, F
    Vandelemmens, C
    Conti, F
    Pageaux, G
    Cherqui, D
    Dhumeaux, D
    JOURNAL OF HEPATOLOGY, 2001, 34 : 48 - 48
  • [3] Hepatitis C virus infection with hepatocellular carcinoma: Not a controversial indication for liver transplantation
    Rodriguez-Luna, H
    Balan, V
    Sharma, P
    Byrne, T
    Mulligan, D
    Rakela, J
    Vargas, HE
    TRANSPLANTATION, 2004, 78 (04) : 580 - 583
  • [4] PERCUTANEOUS RADIOFREQUENCY (PRFA) AS A BRIDGE TO LIVER TRANSPLANTATION (LT) FOR HEPATOCELLULAR CARCINOMA (HCC)
    Smail, Allaoua
    Adam, Rene
    Sebagh, Mylene
    Vibert, Eric
    Salloum, Chady
    Cotta, Fabiano Perdigao
    Benkabbou, Amine
    Duclos-Vallee, Jean-Charles
    Saliba, Faouzi
    Azoulay, Daniel
    Samuel, Didier
    Guettier, Catherine
    Castaing, Denis
    TRANSPLANT INTERNATIONAL, 2009, 22 : 325 - 326
  • [5] NATURAL HISTORY OF RECURRENT HEPATOCELLULAR CARCINOMA (HCC) AFTER LIVER TRANSPLANTATION (LT)
    Dharancy, S.
    Hollebeeque, A.
    Boleslawski, E.
    Declerck, N.
    Canva, V.
    Mathurin, P.
    Pruvot, F. R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S129 - S129
  • [6] Role of Immunosuppression (IS) in the Recurrence of Hepatocellular Carcinoma (HCC) after Liver Transplantation (LT)
    Lai, Q.
    Graziadei, I
    Pinheiro, R. S.
    Vogel, W.
    Lerut, J.
    TRANSPLANTATION, 2012, 94 (10) : 757 - 757
  • [7] THE IMPACT OF HEPATOCELLULAR CARCINOMA (HCC) ON LIVER TRANSPLANTATION (LT) IN THE UNITED STATES (US)
    Younossi, Zobair M.
    Harring, Michael
    Kabbara, Khaled W.
    Eberly, Katherine Elizabeth
    Younossi, Youssef
    Ong, Janus
    Alqahtani, Saleh
    Stepanova, Maria
    HEPATOLOGY, 2021, 74 : 908A - 909A
  • [8] Liver Transplantation for Hepatocellular Carcinoma (HCC)
    Farajov, R.
    Yilmaz, C.
    Iakobadze, Z.
    Karaca, C.
    Kilic, K.
    Aksu, G.
    Tosun, A.
    Akan, M.
    Caglayan, Doganay L.
    Kilic, M.
    TRANSPLANTATION, 2017, 101 (05) : 308 - 308
  • [9] Survival benefit associated with liver transplantation (LT) in patients transplanted for hepatocellular carcinoma (HCC)
    Duvoux, C
    Roudot-Thoraval, F
    Traissac, L
    Vanlemmens, C
    Conti, F
    Pageaux, G
    Malassagne, B
    Sockeel, P
    Cherqui, D
    Dhumeaux, D
    JOURNAL OF HEPATOLOGY, 2001, 34 : 48 - 48
  • [10] ROLE OF FDG PET IN PATIENTS SCHEDULED FOR LIVER TRANSPLANTATION (LT) FOR HEPATOCELLULAR CARCINOMA (HCC)
    Decaens, Thomas
    Itti, Emmanuel
    Laurent, Alexis
    Luciani, Alain
    Van Nhieu, Jeanne Tran
    Auriault, Marie Luce
    Evangelista, Eva
    Meignan, Michel
    Mallat, Ariane
    Cherqui, Daniel
    Duvoux, Christophe
    HEPATOLOGY, 2010, 52 (04) : 662A - 662A
12345